Approvals/TGA/PRISTIQ desvenlafaxine (as succinate) 50mg extended release tablet blister pack

Approved

STANDARD

PRISTIQ desvenlafaxine (as succinate) 50mg extended release tablet blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 25db3e9eeba0239f
Product Name: PRISTIQ desvenlafaxine (as succinate) 50mg extended release tablet blister pack
Artg Id: 170674
Artg Name: PRISTIQ desvenlafaxine (as succinate) 50mg extended release tablet blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2010-06-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/008be3754728cb7cda06949e0249abcb.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b815617437480579f9aa5777f664b669.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

25db3e9eeba0239f

Type

Standard